Concepts (317)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Toxicology | 8 | 2020 | 102 | 3.410 |
Why?
|
Anti-HIV Agents | 11 | 2024 | 4558 | 2.240 |
Why?
|
Substance-Related Disorders | 10 | 2024 | 4416 | 2.010 |
Why?
|
Music Therapy | 3 | 2020 | 111 | 1.760 |
Why?
|
Medication Adherence | 14 | 2024 | 2190 | 1.710 |
Why?
|
Biosensing Techniques | 6 | 2022 | 641 | 1.690 |
Why?
|
Music | 4 | 2024 | 249 | 1.520 |
Why?
|
HIV Infections | 16 | 2024 | 17531 | 1.360 |
Why?
|
Homosexuality, Male | 9 | 2024 | 1342 | 1.280 |
Why?
|
Analgesics, Opioid | 13 | 2024 | 3836 | 1.230 |
Why?
|
Water Pollutants, Chemical | 3 | 2021 | 359 | 1.200 |
Why?
|
Emergency Service, Hospital | 16 | 2024 | 7876 | 1.170 |
Why?
|
Wireless Technology | 2 | 2020 | 98 | 1.100 |
Why?
|
Oxycodone | 2 | 2017 | 143 | 1.010 |
Why?
|
Substance Abuse Detection | 4 | 2024 | 301 | 0.970 |
Why?
|
Opioid-Related Disorders | 7 | 2023 | 2177 | 0.950 |
Why?
|
Robotics | 2 | 2021 | 808 | 0.870 |
Why?
|
Diazepam | 2 | 2020 | 215 | 0.810 |
Why?
|
Information Dissemination | 3 | 2020 | 1140 | 0.800 |
Why?
|
Hydroxychloroquine | 3 | 2022 | 429 | 0.790 |
Why?
|
Naloxone | 4 | 2020 | 373 | 0.760 |
Why?
|
Narcotic Antagonists | 4 | 2020 | 590 | 0.730 |
Why?
|
Calcium Channel Blockers | 1 | 2024 | 685 | 0.700 |
Why?
|
Cannabis | 5 | 2023 | 446 | 0.650 |
Why?
|
Toilet Facilities | 1 | 2019 | 26 | 0.650 |
Why?
|
Group Processes | 1 | 2020 | 224 | 0.610 |
Why?
|
Pharmaceutical Preparations | 3 | 2021 | 1083 | 0.600 |
Why?
|
Opiate Substitution Treatment | 2 | 2020 | 452 | 0.600 |
Why?
|
Mentors | 3 | 2023 | 671 | 0.600 |
Why?
|
Hospitals | 3 | 2021 | 3890 | 0.580 |
Why?
|
Geographic Information Systems | 1 | 2020 | 281 | 0.580 |
Why?
|
Copper Sulfate | 1 | 2017 | 13 | 0.580 |
Why?
|
Fentanyl | 4 | 2024 | 457 | 0.570 |
Why?
|
Pain | 5 | 2023 | 5079 | 0.570 |
Why?
|
Poisoning | 2 | 2016 | 254 | 0.560 |
Why?
|
Cannabidiol | 3 | 2024 | 123 | 0.560 |
Why?
|
Chelation Therapy | 1 | 2017 | 76 | 0.550 |
Why?
|
Research Personnel | 3 | 2023 | 590 | 0.550 |
Why?
|
Telemedicine | 4 | 2024 | 3106 | 0.530 |
Why?
|
Writing | 1 | 2018 | 199 | 0.530 |
Why?
|
Financing, Government | 1 | 2020 | 473 | 0.520 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 791 | 0.520 |
Why?
|
Accidents | 1 | 2017 | 164 | 0.520 |
Why?
|
Remote Consultation | 2 | 2016 | 240 | 0.520 |
Why?
|
Stomach Diseases | 1 | 2017 | 134 | 0.510 |
Why?
|
Medical Informatics Applications | 1 | 2017 | 180 | 0.510 |
Why?
|
Radio Frequency Identification Device | 1 | 2015 | 24 | 0.500 |
Why?
|
Patient Care | 1 | 2021 | 629 | 0.490 |
Why?
|
Remote Sensing Technology | 1 | 2016 | 93 | 0.480 |
Why?
|
Efficiency | 1 | 2018 | 480 | 0.480 |
Why?
|
Fractures, Bone | 2 | 2017 | 2041 | 0.480 |
Why?
|
Drug Contamination | 2 | 2017 | 151 | 0.480 |
Why?
|
Telepathology | 1 | 2015 | 77 | 0.470 |
Why?
|
Buprenorphine | 2 | 2020 | 665 | 0.470 |
Why?
|
Coloring Agents | 1 | 2017 | 562 | 0.470 |
Why?
|
Attitude to Computers | 1 | 2015 | 196 | 0.460 |
Why?
|
Triage | 2 | 2021 | 996 | 0.460 |
Why?
|
Gastric Mucosa | 1 | 2017 | 600 | 0.450 |
Why?
|
Pain Threshold | 4 | 2024 | 604 | 0.440 |
Why?
|
Humans | 96 | 2024 | 766011 | 0.430 |
Why?
|
Environmental Monitoring | 1 | 2020 | 1470 | 0.420 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2016 | 314 | 0.420 |
Why?
|
Videoconferencing | 1 | 2015 | 209 | 0.420 |
Why?
|
Patient Acceptance of Health Care | 2 | 2024 | 3230 | 0.410 |
Why?
|
Pandemics | 12 | 2024 | 8699 | 0.410 |
Why?
|
Internet | 5 | 2018 | 3105 | 0.410 |
Why?
|
Medicine | 1 | 2020 | 943 | 0.400 |
Why?
|
Referral and Consultation | 2 | 2015 | 3616 | 0.400 |
Why?
|
Levamisole | 1 | 2011 | 36 | 0.390 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5368 | 0.380 |
Why?
|
Feasibility Studies | 6 | 2022 | 5304 | 0.380 |
Why?
|
Adult | 38 | 2024 | 223109 | 0.380 |
Why?
|
Resuscitation | 1 | 2016 | 679 | 0.380 |
Why?
|
Capsules | 3 | 2019 | 193 | 0.370 |
Why?
|
Masks | 3 | 2022 | 209 | 0.370 |
Why?
|
Suicide, Attempted | 1 | 2020 | 1412 | 0.370 |
Why?
|
Cannabinoids | 2 | 2024 | 174 | 0.360 |
Why?
|
Cocaine | 2 | 2016 | 945 | 0.360 |
Why?
|
Calcium | 1 | 2024 | 5765 | 0.350 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3099 | 0.350 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3479 | 0.350 |
Why?
|
Emergency Medicine | 1 | 2020 | 1221 | 0.350 |
Why?
|
Blood Coagulation Disorders | 1 | 2014 | 350 | 0.350 |
Why?
|
Male | 43 | 2024 | 363808 | 0.350 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2015 | 698 | 0.350 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3222 | 0.350 |
Why?
|
Electronics | 2 | 2022 | 314 | 0.340 |
Why?
|
Faculty, Medical | 1 | 2018 | 1219 | 0.340 |
Why?
|
Tuberculosis | 1 | 2022 | 2013 | 0.330 |
Why?
|
Harm Reduction | 2 | 2020 | 141 | 0.310 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1462 | 0.310 |
Why?
|
Cocaine-Related Disorders | 1 | 2011 | 458 | 0.300 |
Why?
|
Biomedical Research | 2 | 2023 | 3457 | 0.300 |
Why?
|
Neoplasms | 11 | 2024 | 22350 | 0.290 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2206 | 0.290 |
Why?
|
Antidotes | 2 | 2020 | 138 | 0.280 |
Why?
|
Skin Diseases | 1 | 2015 | 1082 | 0.270 |
Why?
|
Radio Waves | 2 | 2019 | 246 | 0.260 |
Why?
|
Equipment Design | 4 | 2020 | 3487 | 0.260 |
Why?
|
Neutropenia | 1 | 2011 | 893 | 0.260 |
Why?
|
Heart Arrest | 1 | 2016 | 1517 | 0.260 |
Why?
|
Sexual Behavior | 3 | 2024 | 2192 | 0.240 |
Why?
|
Dermatology | 1 | 2015 | 906 | 0.240 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2024 | 2204 | 0.240 |
Why?
|
Pain Measurement | 5 | 2024 | 3560 | 0.230 |
Why?
|
Benzoyl Peroxide | 1 | 2024 | 22 | 0.230 |
Why?
|
Benzene | 1 | 2024 | 106 | 0.220 |
Why?
|
Pilot Projects | 5 | 2022 | 8733 | 0.220 |
Why?
|
Middle Aged | 23 | 2024 | 223058 | 0.210 |
Why?
|
Female | 33 | 2024 | 396159 | 0.210 |
Why?
|
Weapons | 1 | 2022 | 17 | 0.210 |
Why?
|
Privacy | 2 | 2022 | 232 | 0.200 |
Why?
|
Disaster Planning | 2 | 2020 | 559 | 0.200 |
Why?
|
Coturnix | 1 | 2022 | 22 | 0.200 |
Why?
|
North Carolina | 2 | 2020 | 329 | 0.200 |
Why?
|
Condoms | 1 | 2024 | 336 | 0.200 |
Why?
|
Directly Observed Therapy | 1 | 2022 | 139 | 0.200 |
Why?
|
Explosive Agents | 1 | 2022 | 26 | 0.190 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2771 | 0.190 |
Why?
|
Poisons | 1 | 2022 | 37 | 0.190 |
Why?
|
Hemorrhage | 1 | 2014 | 3463 | 0.190 |
Why?
|
Glucuronides | 1 | 2021 | 20 | 0.190 |
Why?
|
Point-of-Care Systems | 2 | 2023 | 1217 | 0.190 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3926 | 0.190 |
Why?
|
Mass Spectrometry | 2 | 2020 | 2193 | 0.190 |
Why?
|
Adenine | 2 | 2024 | 994 | 0.180 |
Why?
|
Social Stigma | 2 | 2024 | 787 | 0.180 |
Why?
|
Tandem Mass Spectrometry | 2 | 2024 | 1194 | 0.180 |
Why?
|
Chemical Terrorism | 1 | 2020 | 12 | 0.180 |
Why?
|
Accidents, Traffic | 2 | 2020 | 818 | 0.180 |
Why?
|
Silicone Elastomers | 1 | 2020 | 78 | 0.180 |
Why?
|
Personnel, Hospital | 1 | 2022 | 286 | 0.180 |
Why?
|
Respiratory Protective Devices | 1 | 2020 | 47 | 0.170 |
Why?
|
Vasoconstrictor Agents | 1 | 2024 | 655 | 0.170 |
Why?
|
Computers | 1 | 2022 | 588 | 0.170 |
Why?
|
Pain Perception | 2 | 2023 | 198 | 0.170 |
Why?
|
Civil Defense | 1 | 2022 | 114 | 0.170 |
Why?
|
Phlebotomy | 1 | 2021 | 138 | 0.170 |
Why?
|
Solid Phase Extraction | 1 | 2020 | 28 | 0.170 |
Why?
|
Prospective Studies | 10 | 2024 | 54818 | 0.170 |
Why?
|
Sexual Partners | 1 | 2024 | 804 | 0.160 |
Why?
|
Fibromyalgia | 1 | 2024 | 406 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 364 | 0.160 |
Why?
|
Therapeutic Equivalency | 1 | 2019 | 134 | 0.160 |
Why?
|
Bicycling | 1 | 2020 | 176 | 0.160 |
Why?
|
Young Adult | 10 | 2024 | 59870 | 0.160 |
Why?
|
Risk-Taking | 1 | 2024 | 1021 | 0.150 |
Why?
|
Chromatography, Liquid | 2 | 2024 | 991 | 0.150 |
Why?
|
United States | 14 | 2024 | 72914 | 0.150 |
Why?
|
Tobacco, Smokeless | 1 | 2019 | 132 | 0.150 |
Why?
|
Communication Barriers | 1 | 2021 | 418 | 0.150 |
Why?
|
Anticoagulants | 1 | 2014 | 4863 | 0.150 |
Why?
|
Amphetamine-Related Disorders | 1 | 2018 | 80 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2024 | 1239 | 0.150 |
Why?
|
Safety | 1 | 2022 | 1158 | 0.150 |
Why?
|
Trust | 1 | 2023 | 532 | 0.150 |
Why?
|
Hallucinogens | 1 | 2021 | 211 | 0.150 |
Why?
|
Sexually Transmitted Diseases | 1 | 2024 | 667 | 0.140 |
Why?
|
Terrorism | 1 | 2020 | 211 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2021 | 1527 | 0.140 |
Why?
|
Urban Health | 1 | 2020 | 530 | 0.140 |
Why?
|
Professional Role | 1 | 2020 | 314 | 0.140 |
Why?
|
Monitoring, Ambulatory | 1 | 2020 | 357 | 0.140 |
Why?
|
Boston | 4 | 2024 | 9341 | 0.140 |
Why?
|
Glass | 1 | 2017 | 116 | 0.140 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1741 | 0.130 |
Why?
|
Mouth Mucosa | 1 | 2019 | 432 | 0.130 |
Why?
|
Heroin | 1 | 2017 | 120 | 0.130 |
Why?
|
Heroin Dependence | 1 | 2017 | 175 | 0.130 |
Why?
|
Methamphetamine | 1 | 2018 | 166 | 0.130 |
Why?
|
Narcotics | 1 | 2018 | 333 | 0.130 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 724 | 0.130 |
Why?
|
Administration, Oral | 1 | 2024 | 4015 | 0.130 |
Why?
|
Potassium | 1 | 2020 | 1310 | 0.130 |
Why?
|
Methadone | 1 | 2018 | 319 | 0.130 |
Why?
|
Complementary Therapies | 1 | 2020 | 487 | 0.130 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26283 | 0.130 |
Why?
|
Aircraft | 1 | 2017 | 135 | 0.130 |
Why?
|
Transducers | 1 | 2017 | 239 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2023 | 4057 | 0.130 |
Why?
|
Catheterization | 1 | 2021 | 1434 | 0.120 |
Why?
|
Automobile Driving | 1 | 2020 | 441 | 0.120 |
Why?
|
Editorial Policies | 1 | 2020 | 458 | 0.120 |
Why?
|
Systems Integration | 1 | 2017 | 427 | 0.120 |
Why?
|
Publishing | 1 | 2022 | 835 | 0.120 |
Why?
|
Diffusion of Innovation | 2 | 2017 | 722 | 0.120 |
Why?
|
Physical Examination | 1 | 2021 | 1265 | 0.120 |
Why?
|
Poison Control Centers | 1 | 2014 | 76 | 0.120 |
Why?
|
Mass Casualty Incidents | 1 | 2017 | 178 | 0.110 |
Why?
|
Affect | 2 | 2024 | 1498 | 0.110 |
Why?
|
Research Support as Topic | 1 | 2018 | 696 | 0.110 |
Why?
|
Health Personnel | 3 | 2023 | 3389 | 0.110 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1382 | 0.110 |
Why?
|
Eyeglasses | 1 | 2015 | 138 | 0.110 |
Why?
|
Gelatin | 1 | 2015 | 227 | 0.110 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1672 | 0.110 |
Why?
|
Academies and Institutes | 1 | 2015 | 326 | 0.110 |
Why?
|
Walking | 1 | 2020 | 1198 | 0.100 |
Why?
|
Aged | 11 | 2024 | 171233 | 0.100 |
Why?
|
Saliva | 1 | 2017 | 851 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1796 | 0.100 |
Why?
|
Industry | 1 | 2014 | 362 | 0.100 |
Why?
|
Public Health | 2 | 2022 | 2678 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2017 | 1834 | 0.100 |
Why?
|
Limit of Detection | 2 | 2024 | 272 | 0.100 |
Why?
|
Blood Coagulation Factors | 1 | 2014 | 372 | 0.090 |
Why?
|
Program Evaluation | 1 | 2020 | 2501 | 0.090 |
Why?
|
Confidentiality | 1 | 2015 | 607 | 0.090 |
Why?
|
Vitamin K | 1 | 2014 | 312 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1078 | 0.090 |
Why?
|
Video Recording | 1 | 2016 | 970 | 0.090 |
Why?
|
Adolescent | 7 | 2024 | 88804 | 0.090 |
Why?
|
Legislation, Drug | 2 | 2023 | 216 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20125 | 0.090 |
Why?
|
Motorcycles | 1 | 2010 | 42 | 0.090 |
Why?
|
Anxiety | 1 | 2024 | 4674 | 0.080 |
Why?
|
Head Protective Devices | 1 | 2010 | 117 | 0.080 |
Why?
|
RNA, Viral | 3 | 2022 | 2864 | 0.080 |
Why?
|
Social Support | 1 | 2018 | 2191 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2020 | 65236 | 0.070 |
Why?
|
Tissue Engineering | 2 | 2009 | 1855 | 0.070 |
Why?
|
Leukocyte Count | 1 | 2011 | 1603 | 0.070 |
Why?
|
Medical Informatics | 1 | 2014 | 742 | 0.070 |
Why?
|
Viral Load | 3 | 2023 | 3385 | 0.070 |
Why?
|
Benchmarking | 2 | 2024 | 1053 | 0.070 |
Why?
|
Patient Care Team | 1 | 2017 | 2517 | 0.060 |
Why?
|
Phenotype | 1 | 2024 | 16707 | 0.060 |
Why?
|
Self Report | 1 | 2017 | 3774 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15403 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8531 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2017 | 1938 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4425 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8103 | 0.060 |
Why?
|
Physicians | 2 | 2020 | 4587 | 0.060 |
Why?
|
Colorado | 1 | 2023 | 167 | 0.050 |
Why?
|
Ukraine | 1 | 2022 | 151 | 0.050 |
Why?
|
Anti-Anxiety Agents | 1 | 2024 | 402 | 0.050 |
Why?
|
Alanine | 1 | 2024 | 613 | 0.050 |
Why?
|
Hydrogels | 1 | 2007 | 729 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2011 | 2003 | 0.050 |
Why?
|
Software | 1 | 2015 | 4457 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6207 | 0.050 |
Why?
|
Decontamination | 1 | 2021 | 73 | 0.050 |
Why?
|
Virus Shedding | 1 | 2021 | 111 | 0.050 |
Why?
|
Immunoassay | 1 | 2024 | 742 | 0.040 |
Why?
|
Chloroquine | 1 | 2022 | 275 | 0.040 |
Why?
|
Equipment Reuse | 1 | 2020 | 45 | 0.040 |
Why?
|
Community Pharmacy Services | 1 | 2020 | 52 | 0.040 |
Why?
|
Security Measures | 1 | 2020 | 83 | 0.040 |
Why?
|
Rats | 1 | 2016 | 23702 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2020 | 81522 | 0.040 |
Why?
|
Sterilization | 1 | 2020 | 133 | 0.040 |
Why?
|
Catastrophization | 1 | 2023 | 352 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2007 | 1683 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2021 | 291 | 0.040 |
Why?
|
Allied Health Personnel | 1 | 2020 | 156 | 0.040 |
Why?
|
San Francisco | 1 | 2018 | 165 | 0.040 |
Why?
|
Health Services | 1 | 2023 | 756 | 0.040 |
Why?
|
Ethanol | 1 | 2024 | 1324 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 743 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21062 | 0.030 |
Why?
|
Hair | 1 | 2020 | 508 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18289 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2023 | 2108 | 0.030 |
Why?
|
Attitude | 1 | 2021 | 769 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2513 | 0.030 |
Why?
|
Telemetry | 1 | 2017 | 201 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2018 | 59526 | 0.030 |
Why?
|
Drug Interactions | 1 | 2020 | 1416 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 370 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5947 | 0.030 |
Why?
|
Analgesics | 1 | 2021 | 1058 | 0.030 |
Why?
|
Trauma Centers | 1 | 2020 | 950 | 0.030 |
Why?
|
Schools | 1 | 2023 | 1495 | 0.030 |
Why?
|
New England | 1 | 2017 | 1059 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3427 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1856 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2023 | 1786 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1760 | 0.020 |
Why?
|
Morbidity | 1 | 2017 | 1752 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5877 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12433 | 0.020 |
Why?
|
Nurses | 1 | 2020 | 2505 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2017 | 1455 | 0.020 |
Why?
|
Central Nervous System Stimulants | 1 | 2018 | 1167 | 0.020 |
Why?
|
Drug Approval | 1 | 2017 | 818 | 0.020 |
Why?
|
Hexuronic Acids | 1 | 2009 | 144 | 0.020 |
Why?
|
Glucuronic Acid | 1 | 2009 | 148 | 0.020 |
Why?
|
Animals | 2 | 2022 | 168721 | 0.020 |
Why?
|
Forecasting | 1 | 2017 | 2938 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2009 | 379 | 0.020 |
Why?
|
Alginates | 1 | 2009 | 247 | 0.020 |
Why?
|
Education | 1 | 2010 | 531 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3913 | 0.020 |
Why?
|
Cell Aggregation | 1 | 2007 | 238 | 0.020 |
Why?
|
Women's Health | 1 | 2017 | 2083 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3646 | 0.020 |
Why?
|
Albumins | 1 | 2009 | 577 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8321 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10389 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2007 | 329 | 0.020 |
Why?
|
Qualitative Research | 1 | 2017 | 3137 | 0.020 |
Why?
|
Sleep | 1 | 2021 | 4823 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 41652 | 0.010 |
Why?
|
Databases, Factual | 1 | 2020 | 8062 | 0.010 |
Why?
|
Health Education | 1 | 2010 | 1060 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26341 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15833 | 0.010 |
Why?
|
Electrocardiography | 1 | 2016 | 6404 | 0.010 |
Why?
|
Data Collection | 1 | 2010 | 3318 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2018 | 4865 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5746 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14061 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10605 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74870 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2007 | 18972 | 0.010 |
Why?
|
Concepts
(317)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(90)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_